NFE2L2 and lung carcinoma: Even more diseases have been addressed in studies related to Nrf2 since 2011, namely cardiovascular disease, obesity, insulin resistance and diabetes, stroke, and various types of cancer (most notably, breast, hepatocellular, and lung carcinoma) (Figure 4 and Figure 5, Tables S3 and S4).